MedTrace Logo

A Study on Safety and Efficacy of Propofol in Small Children Under 2 Years of Age

NCT03132688 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-04-28

No results posted yet for this study

Summary

This retrospective study the safety and efficacy of intravenous propofol used in children under 2 years of age during general anesthesia for surgery.

Conditions

  • Heart Rate Low
  • Anesthesia; Functional

Interventions

DRUG

Propofol

Intravenous administration with dose of 100-200mcg/kg/min

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hee-Soo Kim, PhD · Seoul National University Hospital

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-20
Primary Completion
2017-04-22
Completion
2017-04-22

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03132688 on ClinicalTrials.gov